Nanomedicine: An Essential Resource in Treatment and Diagnosis of Viral Diseases

Author(s):
Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:

The recent outbreak of COVID-19 is considered to be one of the biggest disasters faced in the history which has already killed 211568 and effected 3065739 people across the world (As on 28th April 2020). Thus, there is an alarming need to discuss novel treatment strategies for treatment of such viral outbreaks. Viral diseases affect millions of people around the world, with a major effect on human health and socio-economic development. The human immunodeficiency virus (HIV) affects more than 40 million people alone. This analysis examines the different nanocarriers (e.g. liposomes, solid lipid nanoparticles, polymeric nanoparticles, etc.) based on methods implemented in the literature and in the clinic to address the numerous challenges faced by the antiviral therapy. This review includes recent strategy devised using Nanomedicine to treat H1N1 Influenza virus.  In this review we also tried to discuss few viruses which help in cancer therapy including recent developments in treatment of COVID-19 using Nanotechnology.

Language:
English
Published:
Pharmaceutical and Biomedical Research, Volume:6 Issue: 1, Mar 2020
Page:
4
magiran.com/p2137720  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!